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Determinants of healthcare utilisation and predictors of outcome in colorectal cancer patients from Northern Iran
We aimed to assess healthcare utilisation (HU), its determinants, as well as its relationship with survival in
colorectal cancer (CRC) patients. This study was conducted on incident CRC cases from Northern Iran.
Information on HU was collected using a valid questionnaire, considering eight diagnostic and four
therapeutic services. The results were categorised as good and poor HU. Multivariate logistic regression
analysis was used to assess the relationship between HU and other variables. Cox regression analysis was
performed to determine major predictors of survival. In total, 227 new cases of CRC were enrolled. HU
could be assessed in 218 subjects (96%). Living in rural areas was the strongest variable related to poor HU
(adjusted OR, odds ratio = 2.65; CI, confidence interval: 1.30–5.40). The median survival time was
40.5 months. The 1-, 3- and 5-year survival rates were 71%, 52% and 44% respectively. Cox regression
analysis showed a significant lower survival rate in patients with poor HU (HR = 2.3; CI: 1.46–3.64). HU
was an independent predictor of survival in our CRC patients. Patients’ place of residence was a significant
determinant of HU. Regarding its effects on patients’ outcome, HU and its determinants should be
considered in designing CRC controlling programmes in our region and similar high-risk populations.
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INTRODUCTION
Colorectal cancer (CRC) is the third most common cancer
in men and the second in women worldwide (Ferlay et al.
2013). Different reports suggested increasing trends in
incidence rate of CRC during recent decades (Boyle &
Langman 2000). Genetic predisposition, alcohol intake,
low physical activity, obesity, higher intakes of red and
processed meat, have been suggested as risk factors for
CRC, while higher intakes of dietary fibre, green leafy
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vegetables, some micronutrients such as folate, and cal-
ciumwere reported to be protective factors (Kim 2009; Fer-
lay et al. 2013).
Healthcare utilisation (HU) was considered as an indica-
tor of outcome in different conditions (Acurcio Fde et al.
1998). Appropriate access to healthcare services (early
detection and treatment) may play a pivotal role in
controlling CRC, resulting in reducing its burden in the
community, especially in high-risk areas. Different factors
may affect HU in patients, including pathophysiology and
natural course of disease (Baser et al. 2012) as well as sub-
ject’s socio-demographic characteristics (Roshandel et al.
2011; Malqvist et al. 2013). Assessing the status of HU, its
determinants, as well as its relationship with patients’
outcome may provide valuable evidences to health policy
makers and may help them to develop appropriate inter-
ventions for controlling CRC.
Golestan province located in Northern Iran has been
known as a high-risk area for upper gastrointestinal can-
cers (Mahboubi et al. 1973). Similar to other parts of the
developing world, recent reports suggested an increase in
the incidence of CRC in this region (Roshandel et al.
2012). The results of the Golestan Population-based Can-
cer Registry (GPCR) showed that CRC is the fourth and
fifth most common cause of cancer in men and women
from Golestan province respectively (Semnani et al. 2009;
Roshandel et al. 2012). So, as in many developed and
developing regions (Boyle & Langman 2000; Eser et al.
2010), CRC may be considered as a priority in health
policy making in Golestan province of Iran.
This study was conducted to assess HU, its associated
factors, as well as its relationship with CRC-specific sur-
vival in CRC patients from this region.
METHODS
This cross-sectional study was conducted on new
pathologically confirmed primary CRC cases, diagnosed
between 2006 and 2007 in Golestan province of Iran. Data
on demographic factors and characteristics of tumour
including stage were obtained from the GPCR (Roshandel
et al. 2012). Stage of tumour was identified using instruc-
tions of summary staging system, developed by the sur-
veillance epidemiology and end results (SEER) programme
of the National Health Institute (NIH) (Young et al. 2001).
Data on HU were collected using a structured question-
naire. The validity and reliability of the questionnaire was
approved in a previous study from our region (Roshandel
et al. 2011). Healthcare utilisation index (HUI) was calcu-
lated using previously described methods (Roshandel
et al. 2011). In brief, we considered eight diagnostic proce-
dures (faecal occult blood test, abdominal X-ray, abdomi-
nal ultrasonography, CT-scan, MRI, Barium enema,
colonoscopy and radionuclide imaging) and four therapeu-
tic services (surgery, colonoscopy, chemotherapy and
radiotherapy). For each service, two questions were asked
including, ‘if the procedure was recommended to patient’
and ‘if the procedure was performed for patient’. Answers
‘Yes’ and ‘No’ were scored as ‘1’ and ‘0’ respectively. HUI
was calculated by dividing the sum of performed to the
sum of recommended procedures. According to the distri-
bution of HUI and considering the median, an HUI of 1 (i.e.
all recommended services were performed for the patient)
was considered as good HU and HUIs of less than 1 were
considered as poor HU. Data on recommendation and per-
forming healthcare services for patients (only those related
to diagnosis or treatment of CRC) were collected through
personal interview by expert interviewers. In addition,
patients’ hospital files as well as all other clinical and para-
clinical records were also reviewed for relevant informa-
tion. If the patient was dead at the time of interview, a
first-degree relative was asked to provide valid information.
Using the median of age, subjects were categorised into
two age groups. Multivariate logistic regression analysis
was used to assess the relationship between HU and other
variables. Crude and adjusted odds ratios (OR) as well as
the 95% confidence intervals (CIs) were calculated. The
1-, 3- and 5-year CRC-specific survival rates were calcu-
lated. Deaths attributed to causes other than CRC were
censored. Log rank test was used to compare survival rates
between different groups of variables. Cox regression
analysis was performed to assess the effects of different
variables on patients’ survival. Crude and adjusted hazard
ratios as well as 95% CIs were calculated. P-values of less
than 0.05 were considered as significant. This study was
approved by the ethical committee of Golestan University
of Medical Sciences (GOUMS).
RESULTS
Among 278 eligible CRC cases, 227 patients (81.7%) could
be accessed and were enrolled in this study. The median of
participants’ age was 54 years with interquartile range of
44–66 years. Of participants 138 (60.79%) were male. The
stage of tumour was identified in 209 cases (92.1%), of
which, 42 (20.1%), 105 (50.2%) and 62 (29.7%) were local-
ised, regional and distant metastasis respectively. HUI
could be assessed in 218 subjects (96%). Of these, 128 sub-
jects (58.7%) had good HU and 90 cases (41.3%) had poor
HU. Table 1 shows the relationship between HU and dif-
ferent variables. The results of multivariate analysis sug-
gested a significant relationship between HU and subjects’
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place of residences. The proportion of subjects with poor
HU was significantly higher in participants from rural
areas. We found no significant relationship between HU
and other variables.
The median (95% CI) time of subjects’ survival was 40.5
(24.83–56.17) months. The 1-, 3- and 5-year survival rates
were 71%, 52% and 44% respectively. Table 2 shows the
1-, 3- and 5-year survival rates among different groups of
variables. In univariate analysis, there were significant
relationships between subjects’ survival with stage of
tumour (Table 2, Fig. 1), HU (Table 2, Fig. 2), and comple-
mentary insurance coverage (Table 2).
The results of Cox regression analysis showed that
stage of tumour, HU and place of residents were the
Table 1. Relationship between subjects’ socio-demographic factors and stage of tumour with healthcare utilisation (HU) in colorectal
cancer patients from Golestan province, Iran
Variables Total number*
Number (%) of
subjects with
poor HU
Crude OR
(95% CI) P
Adjusted OR
(95% CI) P
Gender
Male 133 46 (34.59) – – –
Female 85 44 (51.76) 2.03 (1.16–3.54) 0.01 1.85 (0.95–3.61) 0.07
Age groups
<54 105 43 (40.95) – – – –
≥54 113 47 (41.59) 1.03 (0.60–1.76) 0.92 1.03 (0.50–2.13) 0.93
Education
Educated 118 34 (28.81) – – – –
Illiterate 84 40 (47.62) 2.25 (1.25–4.03) <0.01 1.79 (0.85–3.77) 0.13
Place of residence
Urban 104 36 (34.61) – – – –
Rural 111 52 (46.85) 1.67 (0.96–2.88) 0.07 2.65 (1.30–5.40) <0.01
Complementary insurance coverage
No 148 53 (35.81) – – – –
Yes 53 20 (37.73) 1.09 (0.57–2.08) 0.80 1.60 (0.75–3.42) 0.22
Stage of tumour
Localised 42 17 (40.48) – – – –
Regional 101 32 (31.68) 0.68 (0.32–1.44) 0.31 0.44 (0.19–1.02) 0.06
Distant 59 34 (57.63) 2 (0.89–4.47) 0.09 1.25 (0.50–3.11) 0.63
OR, odd ratio; CI, confidence interval.
*Missing data were excluded.
Table 2. Colorectal cancer-specific survival rates according to socio-demographic factors and stage of tumour in Golestan province, Iran
Variables
1-year survival
(%)
3-year survival
(%)
5-year survival
(%)
Median survival
(month) P-value*
Healthcare utilisation
Good 76 66 57 71.10 <0.01
Poor 60 30 25 15.73
Stage of tumour
Localised 100 92 80 Not reached <0.01
Regional 93 62 51 63.27
Distant 10 02 02 4.77
Gender
Male 73 52 48 44.23 0.36
Female 69 50 38 38.63
Age groups
<54 69 49 40 34.67 0.61
≥54 73 53 49 51.97
Education
Educated 72 58 50 63.27 0.46
Illiterate 77 53 45 46.97
Place of residence
Urban 74 57 50 61.40 0.14
Rural 69 47 39 34.50
Complementary insurance coverage
Yes 83 67 63 Not reached 0.02
No 71 52 44 42.8
*Log rank test.
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strongest variables related to survival in CRC patients
(Table 3).
DISCUSSION
Healthcare utilisation is an important indicator of out-
come in many conditions. The increasing trend in inci-
dence of CRC suggested it as an important heath problem
in the developed world as well as the developing countries.
We aimed to assess major determinants of HU and its
effect on patients’ survival in Northern Iran.
Our results suggested that patients’ place of residence
was the strongest variable related to their access to health-
care services. The proportion of subjects with poor HU
was significantly higher in residents of rural areas than
those from urban areas. Geographic disparities in access to
healthcare services were reported in different groups of
patients. Cooper et al. (1999) reported differences in the
use of follow-up procedures in CRC patients across geo-
graphic regions. The results of a study from Mexico
showed significant inverse relationship between travel
distance and receipt of radiotherapy in patients with breast
cancer (Athas et al. 2000). Geographical distance to health
services providers is an important determinant of patients’
utilisation of healthcare services. So, geographical distri-
bution of patients should be considered as a major crite-
rion for allocating healthcare resources. This may help to
ensure effective and ethical allocation of resources in
health systems, especially in low-resources settings.
We found higher proportions of poor HU if female sub-
jects, illiterate subjects and subjects with distant metasta-
sis, although none of these relationships were significant.
Previous studies also reported relationships between HU
and patients’ socio-demographic characteristics (Viljoen
et al. 2013). Polite et al. (2006) reported differences in the
receipt of appropriate therapy between African Americans
and White CRC patients. Other studies suggested racial
and ethnic disparities in HU among CRC and other cancer
patients (Shavers & Brown 2002; Berry et al. 2009; White
et al. 2010). Heath insurance and tumour characteristics
coverage were also reported as a determinant of access to
healthcare services in CRC patients (Roetzheim et al.
2000; White et al. 2010).
Healthcare utilisation may be affected by different fac-
tors including patient-related (e.g. socio-demographic) as
well as tumour-related factors (e.g. stage of tumour). Iden-
tifying major determinants of HU in each region may be
helpful in designing appropriate interventions to ensure
ethical distribution of healthcare services and conse-
quently may result in implementation of effective control-
ling programmes.
Subject’s refusal to get healthcare may be considered as
a possible reason for poor HU in some cases. This may just
occur due to lack of knowledge or negative attitude
towards efficacy of a healthcare service. Such condition
should be differentiated from a situation in which a
patient does not have access to a healthcare service. As a
limitation of the present study, we could not assess this
point in our subjects. So, it is recommended to consider
and control this variable in future studies.
Our findings showed a significant relationship between
HU and survival rate in CRC patients. We found signifi-
Figure 1. Colorectal cancer-specific survival in Golestan, Iran
according to stage of cancer. *Log rank test.
Figure 2. Colorectal cancer-specific survival in Golestan, Iran
according to healthcare utilisation status. Solid line indicates
poor healthcare utilisation and dash line indicates good health-
care utilisation. *Log rank test.
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cant lower survival rates in subjects with poor HU. The
relationship between HU and subjects’ survival rate
remained statistically significant even after adjusting for
other variables including the stage on tumour, place of res-
idence, gender, age, education and complementary insur-
ance coverage (Table 3). So, our results suggested an
independent association between HU and survival. The
results of a study from the USA showed a lower CRC
mortality in Medicare beneficiaries with higher utilisation
of primary care (Ferrante et al. 2013). Yim et al. (2012)
have also reported an independent effect of HU on survival
rates in patients with CRC and stomach cancer. Access to
medical care was suggested as an important determinant
of survival (Chaisson et al. 1995; Acurcio Fde et al. 1998).
HU, as a predictor of patient outcome, should be taken
into account in CRC controlling programmes, especially
in high-risk areas. Fair access to healthcare services among
CRC patients may ensure better outcome and may result
in reducing the burden of this disease in the community.
Stages of tumour, patients’ place of residence as well as
age were related to survival rates in our CRC subjects. Bio-
logical characteristics of tumour, including stage, were
known as important predictors of survival in cancer
patients. A number of patient’s socio-demographic factors
including race (Chien et al. 2005; Alexander et al. 2007),
education (Aarts et al. 2013), insurance coverage (Roetz-
heim et al. 2000), socioeconomic status (Fitzgerald et al.
2014) and age (Lee et al. 2013) were also suggested as
determinants of outcome in CRC and other cancer
patients. There were discrepancies in the strength of
association between these factors and patients’ survival
rates among different populations. Determination of
major predictors of survival may play a pivotal role in
designing appropriate interventions for reducing the
burden of cancers, especially in low-resources settings.
Therefore, further large-scale studies are warranted to
identify all possible predictors of CRC survival in our
region as well as other high-risk populations.
In conclusion, our results suggested HU as an indepen-
dent predictor of survival in CRC patients. We also found
a significant relationship between patients’ place of resi-
dence and HU in these patients. Regarding its importance
on patients’ outcome, HU and its determinants should be
considered in designing CRC controlling programmes in
our population and other high-risk areas.
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Table 3. Cox regression analysis of factors predicting survival in colorectal cancer patients from Golestan province, Iran
Variables
Univariate analysis Multivariate analysis
Crude hazard ratio 95% CI P-value Adjusted hazard ratio 95% CI P-value
Healthcare utilisation
Good – – <0.01 – – <0.01
Poor 2.46 1.71–3.54 2.30 1.46–3.64
Stage of tumour
Localised – – <0.01 – – <0.01
Regional 2.96 1.45–6.07 4.27 1.98–9.21
Distant 46.45 21.94–93.34 72.33 30.36–172.34
Gender
Male – – 0.36 – – 0.89
Female 1.18 0.83–1.68 1.03 0.66–1.60
Age groups
≥54 – – 0.61 – – 0.05
<54 1.09 0.77–1.55 1.55 1.00–2.39
Education
Educated – – 0.46 – –
Illiterate 1.15 0.79–1.68 0.97 0.61–1.54 0.90
Place of residence
Urban – – 0.14 – –
Rural 1.30 0.91–1.85 1.66 1.02–2.70 0.04
Complementary insurance coverage
Yes – – 0.02 – –
No 1.83 1.11–3.00 1.54 0.89–2.67 0.12
CI, confidence interval.
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